Therapeutic targets for aggressive triple-negative breast cancers

As part of a breast-cancer diagnosis, doctors analyze the tumour to determine which therapies might best attack the malignancy. But for patients whose cancer is triple-negative -- that is, lacking receptors for estrogen, progesterone and Her2 -- the...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2saoZIg
via IFTTT